荧光猝灭法测定次黄嘌呤及机理研究

研究了次黄嘌呤猝灭伊文思蓝的荧光猝灭机理并根据次黄嘌呤对伊文思蓝荧光的猝灭作用建立了测定次黄嘌呤的新方法.线性回归方程为:ρ=6.292×103F-1-26.49,相关系数为0.9990,线性范围为0.20～20.0 μg/mL,检出限为0.14 μg/mL,相对标准偏差(RSD)为2.5%.求算了伊文思蓝与次黄嘌呤的形成常数K=2.63×102L/moL,实验了pH、放置时间、干扰离子等对测定的影响.     

咔唑及其衍生物对 9-氰基蒽的荧光猝灭机理的研究

本文研究咔唑及其衍生物对9-氰基蒽(9CNA)的荧光猝灭机理。结果表明, 猝灭过程有以下三种方式:(1)一系列N-烷基咔唑及1,4-二咔唑丁烷、反式1,2-二咔唑环丁烷、N-苄基咔唑等对9CNA的荧光猝灭是通过形成激基复合物。(2)咔唑对9CNA的荧光猝灭是通过形成氢键。(3)1,3-二咔唑丙烷及N-痖烯基咔唑对9CNA的荧光猝灭是属于一般碰撞猝灭过程。以上所有猝灭过程主要都是来自电荷转移相互作用。另外, 还讨论了空间位阻对形成激基复合物的影响。并由稳态和动态荧光实验结果,应用Ware关于激基复合物的形成和解离的动力学公式计算出一系列光物理速率常数。     

Interaction of tetrandrine with human serum albumin: a fluorescence quenching study.

The interaction of tetrandrine with human serum albumin (HSA) was studied by measuring fluorescence quenching spectra, synchronous fluorescence spectra and ultra-violet spectra. The fluorescence quenching spectra of HSA in the presence of tetrandrine showed that tetrandrine quenched the fluorescence of HSA. The quenching constants of tetrandrine on HSA were determined using the Stern-Volmer equation. Static quenching and non-radiation energy transfer were the two main reasons leading to the fluorescence quenching of HSA by tetrandrine. According to the F?rster theory of non-radiation energy transfer, the binding distances (r) and the binding constants (K(A)) were obtained. The thermodynamic parameters obtained in this study revealed that the interaction between tetrandrine and HSA was mainly driven by a hydrophobic force. The conformational changes of HSA were investigated by synchronous spectrum studies.     

铕敏化荧光法测定人体血清和尿液中的芦氟沙星

:研究了测定人体血清和尿样中芦氟沙星 ( RFX)的铕敏化荧光法。在HAc- Na Ac缓冲溶液中 ,RFX与 Eu3 +、EDTA形成三元配合物 ,产生了 Eu2 +的特征荧光 ,据此建立了直接、快速测定人体血清和尿液中的芦氟沙星含量的方法。测定在血清和尿液中 RFX浓度的线性范围分别为 2 .5× 1 0 -8～ 1 .0× 1 0 -6mol· L-1和 1 .0× 1 0 -7～ 5.0× 1 0 -6mol· L-1,检出限为 6.6× 1 0 -9mol· L-1和 1 .5× 1 0 -8mol· L-1。     

High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.

A simple and sensitive high-performance liquid chromatographic method with ultraviolet detection is described for the simultaneous determination of lansoprazole and its metabolites in human serum and urine. The analytes in serum or urine were extracted with diethyl ether-dichloromethane (7:3, v/v) followed by evaporation, dissolution and injection into a reversed-phase column. The recoveries of authentic analytes added to serum at 0.05-2 micrograms/ml or to urine at 1-20 micrograms/ml were greater than 88%, with the coefficients of variation less than 7.1%. The minimum determinable concentrations of all analytes were 5 ng/ml in serum and 50 ng/ml in urine. The method was successfully applied to a pharmacokinetic study of lansoprazole in human.     

测定人体尿液中苄基丙二酸的免疫分析新方法研究

将苄基丙二酸(BA)与牛血清白蛋白通过活化酯法偶联制备人工免疫原,然后免疫新西兰大白兔制得抗苄基丙二酸多克隆抗体;使用该抗体建立了测定人体尿液中的苄基丙二酸的间接竞争酶联免疫吸附方法(ic-ELISA),方法线性范围为1.0×10-2～1.0×103ng/mL,最低检测浓度为0.01 ng/mL,板内差异为5.5%,板间差异在3.8%～7.8%的范围内;用于实际尿样中苄基丙二酸的测定,回收率为87.8%～115.1%。     

Stopped-flow determination of creatinine in human serum and food samples

Summary The results obtained by applying a modular stopped-flow system for the determination of creatinine by the alkaline picrate method are reported. The stopped-flow technique allows the simple and rapid determination of creatinine in human serum and food samples. The calibration graph is linear in the range 1–100 g ml^–1 of creatinine and the precision is close to 3%. The method features acceptable selectivity. The initial rate is measured in only 5 s, which allows the easy application of the method to routine analyses. No pretreatment of the serum samples is required. For food samples, total creatine and creatinine have been determined in dehydrated soup and meat extract samples.

---

Stopped-flow-Bestimmung von Creatinin in Humanserum und Nahrungsmitteln

     

Determination of ciprofloxacin in human urine and serum samples by solid-phase spectrofluorimetry

A method for the determination of trace amounts of ciprofloxacin has been developed, based on solid-phase spectrofluorimetry. The relative fluorescence intensity of ciprofloxacin fixed on Sephadex SP C-25 gel was measured directly after packing the gel beads in a 1-mm silica cell, using a solid-phase attachment. The wavelengths of excitation and emission were 272 and 448 nm, respectively. Using a sample volume of 1000 ml, the linear concentration range of application was 0.3-10.0 ng.ml(-1) of ciprofloxacin, with a R.S.D. of 1.2% (for a level of 4.0 ng.ml(-1)) and a detection limit of 0.1 ng.ml(-1). The method was applied to the determination of ciprofloxacin in human urine and serum samples. It was validated applying the standard addition methodology and using HPLC as a reference method. Recovery levels of the method reached 100% in all cases.     

Group-selective determination of total N-nitroso compounds in nitrate-containing human urine samples

A group-selective method for the determination of total N-nitroso compounds (NOC) has been adapted for analysing human urine samples. Nitrate was first removed from urine by an anion-exchange procedure that prevented the significant loss of various added reference NOC and unidentified urinary NOC. The total NOC were then determined by injecting the urine sample (nitrate content less than 1 mmol l-1) or anion-exchange eluate into refluxing ethyl acetate containing either acetic acid for determining heat and acetic acid labile thermal energy analyser responsive compounds (TAC) or into hydrogen bromide for the determination of TAC and NOC. The nitrogen monoxide levels released were measured using thermal energy analysis with chemiluminescence detection, and the differnce between the two determinations represented the concentrations of NOC. The optimum conditions for preventing artefactual nitrosation in urine samples by the addition of sodium hydroxide or sulphamic acid without decomposition of NOC were determined. The influence of time and storage conditions on NOC stability was investigated. Fifteen urine samples collected from volunteers dosed with proline were analysed for total NOC and N-nitrosamino acids revealing a preponderance of unknown NOC. The determination of total NOC in human urine using this group-selective method offers a new approach to the estimation of human exposure to NOC and to isolate hitherto unknown NOC and their metabolites.     

Study of a molecular imprinting polymer coated BAW bio-mimic sensor and its application to the determination of caffeine in human serum and urine

A bio-mimic bulk acoustic wave (BAW) sensor was fabricated by coating the caffeine (CAF) template molecular imprinting polymer (MIP). This sensor exhibited high selectivity and a sensitive mass response to CAF. The response range of the sensor was between 5.0 x 10(-9) and 1.0 x 10(-4) M with a detection limit of 5.0 x 10(-9) M at pH 8.0. Recoveries were 96.1-105.6%. Influencing factors were investigated in detail and optimized. When employed to detect real samples, the proposed method proved to be a convenient method with the advantages of high sensitivity, good selectivity and ease of handling.     

Energy transfer and fluorescence quenching in complexes of polymethine dyes with human serum albumin

Electronic excitation energy transfer (EET) between molecules of polymethine dyes bound to human serum albumin (HSA) has been established and studied by absorption and fluorescence spectroscopy as well as by fluorescence decay measurements. In this system, excitation of the donor dye molecule leads to fluorescence of the acceptor dye molecule, both bound to HSA, with donor fluorescence quenching by the acceptor. The short distance between the donor and the acceptor (25-28 A) revealed from the Forster model of EET as well as some spectroscopic data show that both molecules are probably located in the same binding domain of HSA. The role of HSA is to bring donor and acceptor molecules together to a distance adequate to achieve EET as well as to increase the donor and acceptor fluorescence quantum yields. Efficient quenching of the intrinsic HSA fluorescence by some polymethine dyes (oxonols) is observed. The experimental results fit well a model for the formation of a weakly fluorescent dye-HSA complex; the quencher in this complex should be located in the immediate vicinity of the HSA fluorophore group (Trp(214)).     

Spectrofluorimetric determination of levofloxacin in tablets, human urine and serum

A spectrofluorimetric method to determine levofloxacin is proposed and applied to determine the substance in tablets and spiked human urine and serum. The fluorimetric method allow the determination of 20–3000 ng ml⁻¹ of levofloxacin in aqueous solution containing acetic acid–sodium acetate buffer (pH 4) with λ_exc=292 and λ_em=494 nm, respectively. Micelle enhanced fluorescence improves the sensibility and allows levofloxacin direct measurement in spiked Human serum (5 μg ml⁻¹) and urine (420 μg ml⁻¹), in 8 mM sodium dodecyl sulphate solutions at pH 5.     

Synchronous fluorescence determination of human serum albumin with methyl blue as a fluorescence probe

A new synchronous fluorescence scan analysis was developed for the determination of HSA with high sensitivity with a triphenylmethane acid dye methyl blue as a fluorescence probe. When Deltalambda=140 nm, the synchronous fluorescence peak of methyl blue is located at 323 nm and the synchronous fluorescence intensity of the methyl blue is significantly increased in the presence of trace HSA due to the complex formed between methyl blue and HSA at pH 4.1. Under optimal conditions, the calibration graphs are linear over the range 0.03-266.0 and 266.0-665.0 microg mL(-1) for human serum albumin (HSA). Limit of determination were 0.03 microg mL(-1) for HSA. In the detection of HSA in human serum samples, this method gave values close the clinical data got from hospital.     

Spectrofluorimetric determination of moxifloxacin in tablets, human urine and serum

A spectrofluorimetric method to determine the antibiotic moxifloxacin is proposed and was applied to pharmaceuticals, human urine and serum. The fluorimetric method allows the determination of 30-300 ng mL-1 moxifloxacin in aqueous solution containing phosphoric acid-phosphate buffer (pH 8.3) with lambda exc = 287 nm and lambda em = 465 nm. Detection and quantification limits were 10 and 30 ng mL-1, respectively, with a relative standard deviation (n = 10) of 2%. This method was applied to the determination of moxifloxacin in three Spanish commercial pharmaceutical formulations. Another variant of the method in micellar medium allows the direct measurement of moxifloxacin in human serum and urine by standard additions. The enhanced fluorescence of moxifloxacin in 8 mM sodium dodecyl sulfate (SDS) solution at pH 4.0 (acetic acid-acetate buffer) for lambda exc = 294 nm and lambda em = 503 nm shows the same linear range as the aqueous method with a 25% lower slope (with detection and quantification limits of 15 and 60 ng mL-1, respectively, and a relative standard deviation of 1.3%), but permits the background fluorescence for urine and serum blanks to be minimized. Hence, sufficient sensitivity is reached to determine therapeutic concentrations of the drug in urine (average recovery 102 +/- 2%) and serum (average recovery 105 +/- 2%) samples.     

Photostability studies for micellar liquid chromatographic determination of nifedipine in serum and urine samples

Nifedipine is a photosensitive compound that is converted into its 4-(2-nitrophenyl) pyridine and 4-(2-nitrosophenyl) pyridine homologue. In order to obtain the most adequate conditions for handling nifedipine solutions in the analytical laboratory, a number of studies on the decomposition of this compound were performed. A simple micellar liquid chromatographic procedure was described to determine nifedipine in different biological matrices such as serum and urine, and to control its decomposition. To perform the analysis, nifedipine was dissolved in 0.1 m SDS at pH 3 and chromatographed using a mobile phase containing 0.125 m SDS-3% pentanol, pH 3 on a C18 column and UV detection at 235 nm. The chromatographic analysis time was 8 min. The response of the drug for both biological matrices was linear in the 1-100 microg/mL range, with r2>0.997 at all times. Repeatability, intermediate precision (CV, %) and limits of quantification and detection (ng/mL) were 0.19, 4.3, 104 and 31 in serum and 0.81, 2.1, 136 and 41 in urine. The method developed here does not show interferences or matrix effects produced by endogenous compounds. Micellar media and mobile phases have the advantage of stabilising the compounds, thus preventing photodegradation and allowing the direct injection of biological samples.     

动力学荧光猝灭法测定柠檬酸的研究

在稀H2SO4介质中,柠檬酸活化钒(Ⅴ)催化溴酸钾氧化吡口罗红Y的褪色反应,使其荧光猝灭,建立了动力学荧光猝灭法测定柠檬酸的新方法。反应在沸水浴中进行10min,测定柠檬酸的线性范围为0.1～4.0μg/mL,检出限为6.0×10-8g/L。本法用于饮料中柠檬酸的测定,并进行了加标回收试验,回收率在96%～103%之间。     

Fluorescence and terbium-sensitised luminescence determination of garenoxacin in human urine and serum

Fluorescence and terbium-sensitised luminescence properties of new quinolone garenoxacin have been studied. The fluorimetric method allows the determination of 0.060-0.600 μg ml⁻¹ of garenoxacin in aqueous solution containing HCl/KCl buffer (pH 1.5) with λ_exc=282 nm and λ_em=421 nm. Micellar-enhanced fluorescence was also studied, leading to a higher than 400% increase in analytical signal in presence of 12 mM sodium dodecyl sulphate (SDS), allowing the determination of 0.020-0.750 μg ml⁻¹ of garenoxacin. The terbium-sensitised luminescence method allows the determination of 0.100-1.500 μg ml⁻¹ of garenoxacin in 12 mM SDS solution containing 0.08 M acetic acid/sodium acetate buffer (pH 4.1) and 7.5 mM Na₂SO₃ (chemical deoxygenation agent), with λ_exc=281 nm and λ_em=546 nm. Relative standard deviation (R.S.D.) values for the three methods were in the range 1.0-2.0%. The proposed procedures have been applied to the determination of garenoxacin in spiked human urine and serum.     

Clean-up, detection and determination of salbutamol in human urine and serum

Salbutamol ?2-(tert-butylamino)-1-[4-hydroxy-3- (hydroxymethyl)phenyl]ethanol?, also known as albuterol, is clinically the most widely used beta 2-adrenoceptor agonist in the treatment of bronchial asthma. During this study, we evaluated liquid-liquid extraction (LLE) and solid-phase extraction (SPE) in order to develop a reliable extraction method followed by analysis using liquid chromatography and gas chromatography. An assay is described which involves SPE as the clean-up method followed by gas chromatography-mass spectrometry to determine salbutamol levels in human serum after oral administration. The SPE method requires the use of a hyper-cross-linked styrene-divinylbenzene bonded phase (ENV+) without involving any sample pre-treatment to obtain 60-65% recoveries for salbutamol and terbutaline as the internal standard. Distilled water and 1% trifluoroacetic acid in methanol were found to be the most suitable washing solvent and eluting solvent, respectively. A detection limit of 2 ng mL-1 was achieved by derivatization with N-methyl-N-trimethylsilyltrifluoroacetamide to form trimethylsilyl (TMS)-salbutamol (m/z 369) and TMS-terbutaline (m/z 356). The relationship between the ratio of the peak area of salbutamol to that of the internal standard and concentration was linear for the range tested (2-200 ng mL-1) and the correlation of coefficient was 0.9999 with a y-intercept not significantly different from zero. The inter-day relative standard deviation (RSD) was < 10% for all three concentrations. The intra-day RSD was 14% for 2 ng mL-1. This assay was then successfully applied to human serum samples obtained from clinical trials after oral administration of salbutamol.